{"id":"https://openalex.org/W1996383271","doi":"https://doi.org/10.1586/17512433.2015.977255","title":"Rationale of using hypopigmenting drugs and their clinical application in melasma","display_name":"Rationale of using hypopigmenting drugs and their clinical application in melasma","publication_year":2014,"publication_date":"2014-12-04","ids":{"openalex":"https://openalex.org/W1996383271","doi":"https://doi.org/10.1586/17512433.2015.977255","mag":"1996383271","pmid":"https://pubmed.ncbi.nlm.nih.gov/25474082"},"language":"en","primary_location":{"id":"doi:10.1586/17512433.2015.977255","doi":"https://doi.org/10.1586/17512433.2015.977255","is_oa":false,"landing_page_url":"https://doi.org/10.1586/17512433.2015.977255","pdf_url":null,"source":{"id":"https://openalex.org/S102962966","display_name":"Expert Review of Clinical Pharmacology","issn_l":"1751-2433","issn":["1751-2433","1751-2441"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103178840","display_name":"Kabir Sardana","orcid":"https://orcid.org/0000-0003-1757-3406","observed_orcids":["https://orcid.org/0000-0003-1757-3406"]},"institutions":[{"id":"https://openalex.org/I39190216","display_name":"Maulana Azad Medical College","ror":"https://ror.org/03dwx1z96","country_code":"IN","type":"education","lineage":["https://openalex.org/I110166357","https://openalex.org/I39190216"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Kabir Sardana","raw_affiliation_strings":["Department of Dermatology, Maulana Azad Medical College, and Lok Nayak Hospital, New Delhi, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Maulana Azad Medical College, and Lok Nayak Hospital, New Delhi, India","institution_ids":["https://openalex.org/I39190216"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083386583","display_name":"Sneha Ghunawat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I39190216","display_name":"Maulana Azad Medical College","ror":"https://ror.org/03dwx1z96","country_code":"IN","type":"education","lineage":["https://openalex.org/I110166357","https://openalex.org/I39190216"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sneha Ghunawat","raw_affiliation_strings":["Department of Dermatology, Maulana Azad Medical College, and Lok Nayak Hospital, New Delhi, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Maulana Azad Medical College, and Lok Nayak Hospital, New Delhi, India","institution_ids":["https://openalex.org/I39190216"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5103178840"],"corresponding_institution_ids":["https://openalex.org/I39190216"],"apc_list":null,"apc_paid":null,"fwci":0.1336,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.0796371,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"8","issue":"1","first_page":"123","last_page":"134"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11144","display_name":"melanin and skin pigmentation","score":0.7588000297546387,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11144","display_name":"melanin and skin pigmentation","score":0.7588000297546387,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11172","display_name":"Dermatologic Treatments and Research","score":0.2354000061750412,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melasma","display_name":"melasma","score":0.996999979019165},{"id":"https://openalex.org/keywords/melanin-synthesis","display_name":"melanogenesis","score":0.8040000200271606},{"id":"https://openalex.org/keywords/melanogenesis-inhibitors","display_name":"melanogenesis inhibitors","score":0.6690000295639038},{"id":"https://openalex.org/keywords/ellagic-acid","display_name":"ellagic acid","score":0.996999979019165},{"id":"https://openalex.org/keywords/azelaic-acid","display_name":"azelaic acid","score":0.9990000128746033},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/hyperpigmentation","display_name":"hyperpigmentation","score":0.7919999957084656},{"id":"https://openalex.org/keywords/triple-combination-cream","display_name":"triple combination cream","score":0.5799999833106995},{"id":"https://openalex.org/keywords/in-vitro-to-in-vivo-translation","display_name":"in vitro to in vivo translation","score":0.7210000157356262}],"concepts":[{"id":"https://openalex.org/C2776677263","wikidata":"https://www.wikidata.org/wiki/Q305190","display_name":"Melasma","level":2,"score":0.979973554611206},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8501690626144409},{"id":"https://openalex.org/C2780285341","wikidata":"https://www.wikidata.org/wiki/Q413504","display_name":"Azelaic acid","level":2,"score":0.7982265949249268},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6572849750518799},{"id":"https://openalex.org/C2776728111","wikidata":"https://www.wikidata.org/wiki/Q1641068","display_name":"Hyperpigmentation","level":2,"score":0.6561542749404907},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6353092789649963},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5728186964988708},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.4927501976490021},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4458346366882324},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.11008331179618835},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07325831055641174},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008548","descriptor_name":"Melanosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010858","descriptor_name":"Pigmentation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1586/17512433.2015.977255","doi":"https://doi.org/10.1586/17512433.2015.977255","is_oa":false,"landing_page_url":"https://doi.org/10.1586/17512433.2015.977255","pdf_url":null,"source":{"id":"https://openalex.org/S102962966","display_name":"Expert Review of Clinical Pharmacology","issn_l":"1751-2433","issn":["1751-2433","1751-2441"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:25474082","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25474082","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert review of clinical pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":72,"referenced_works":["https://openalex.org/W124885230","https://openalex.org/W1481792414","https://openalex.org/W1496313323","https://openalex.org/W1523752030","https://openalex.org/W1550461747","https://openalex.org/W1606845678","https://openalex.org/W1859635882","https://openalex.org/W1899214345","https://openalex.org/W1964637929","https://openalex.org/W1967711597","https://openalex.org/W1967766851","https://openalex.org/W1968873637","https://openalex.org/W1972615165","https://openalex.org/W1979702380","https://openalex.org/W1980118456","https://openalex.org/W1985970349","https://openalex.org/W1986133342","https://openalex.org/W1988883719","https://openalex.org/W1989259802","https://openalex.org/W1990545369","https://openalex.org/W1997309595","https://openalex.org/W1997727747","https://openalex.org/W2001144373","https://openalex.org/W2002084912","https://openalex.org/W2002085398","https://openalex.org/W2005261158","https://openalex.org/W2011381935","https://openalex.org/W2016165863","https://openalex.org/W2024175329","https://openalex.org/W2029473170","https://openalex.org/W2029912972","https://openalex.org/W2031951021","https://openalex.org/W2033837699","https://openalex.org/W2041215732","https://openalex.org/W2044086754","https://openalex.org/W2045560488","https://openalex.org/W2054524504","https://openalex.org/W2062395292","https://openalex.org/W2065286430","https://openalex.org/W2071805371","https://openalex.org/W2074005278","https://openalex.org/W2076359990","https://openalex.org/W2081360743","https://openalex.org/W2081766244","https://openalex.org/W2085777985","https://openalex.org/W2091162655","https://openalex.org/W2091901535","https://openalex.org/W2095289520","https://openalex.org/W2095839283","https://openalex.org/W2098266773","https://openalex.org/W2099602020","https://openalex.org/W2101456910","https://openalex.org/W2103744556","https://openalex.org/W2108074348","https://openalex.org/W2114359459","https://openalex.org/W2118157327","https://openalex.org/W2118364917","https://openalex.org/W2121602035","https://openalex.org/W2126945805","https://openalex.org/W2128824521","https://openalex.org/W2130948430","https://openalex.org/W2133095097","https://openalex.org/W2134643552","https://openalex.org/W2138986328","https://openalex.org/W2146897012","https://openalex.org/W2149250648","https://openalex.org/W2149737068","https://openalex.org/W2149946770","https://openalex.org/W2169017387","https://openalex.org/W2187027218","https://openalex.org/W2278132114","https://openalex.org/W2365404016"],"related_works":["https://openalex.org/W4289346876","https://openalex.org/W2035290649","https://openalex.org/W4242768889","https://openalex.org/W2126273158","https://openalex.org/W7018645543","https://openalex.org/W2463290607","https://openalex.org/W2976048781","https://openalex.org/W2055984976","https://openalex.org/W4247295358","https://openalex.org/W4250599492"],"abstract_inverted_index":{"Among":[0],"the":[1,6,28,41,45,48,52,82,86],"pigmentary":[2],"disorders,":[3],"melasma":[4],"is":[5,20,78,90,136],"prototype":[7],"disorder":[8],"characterized":[9],"by":[10],"hyperpigmentation.":[11],"Although,":[12],"conventionally,":[13],"triple":[14],"combination":[15],"creams":[16],"are":[17,99],"used,":[18],"there":[19],"a":[21,72,92,109,115,137],"need":[22,61,93],"for":[23,96],"alternatives":[24],"to":[25,62,94,101],"hydroquinone":[26],"as":[27,103],"drug":[29,76],"has":[30],"restrictions":[31],"on":[32,57],"its":[33],"widespread":[34],"use.":[35],"This":[36],"needs":[37],"an":[38],"understanding":[39],"of":[40],"steps":[42,84],"involved":[43],"in":[44,58,68,85,131],"melanogenesis":[46],"and":[47,125],"drugs":[49,97,117],"that":[50,80,98],"inhibit":[51],"key":[53],"steps.":[54],"The":[55],"data":[56],"vitro":[59],"inhibition":[60],"be":[63],"then":[64,105],"translated":[65],"into":[66],"clinical":[67,111,132],"vivo":[69],"results,":[70],"before":[71],"rationale":[73],"compounded":[74],"fixed":[75],"preparation":[77],"marketed":[79],"inhibits":[81],"major":[83],"pigmentation":[87],"pathway.":[88],"There":[89],"also":[91],"look":[95],"superior":[100],"hydroquinone,":[102],"only":[104],"will":[106],"they":[107],"have":[108,128],"meaningful":[110],"utility.":[112],"For":[113],"now,":[114],"few":[116],"like":[118],"deoxyarbutin,":[119],"ellagic":[120],"acid,":[121,123],"dioic":[122],"n-butylresorcinol":[124],"azelaic":[126],"acid":[127],"such":[129],"properties":[130],"trials,":[133],"while":[134],"metformin":[135],"recent":[138],"addition.":[139]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}